Structure of State Regulatory Authorities REGISTRATION CERTIFICATE ISSUING AUTHORITY ROSZDRAVNADZOR



Similar documents
Importing pharmaceutical products to China

SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT

EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES

Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE

Session 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs

MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION. ORDER 737n October 14, 2013

CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

Official Journal of the European Union. (Acts whose publication is obligatory)

GOVERNMENT OF THE RUSSIAN FEDERATION RESOLUTION from December 27, 2012 N 1416 APPROVAL OF THE RULES STATE REGISTRATION OF MEDICAL PRODUCTS

Introduction to the CTA & NDA process in China

2014 Annual Report on Inspections of Establishments

Part 3 Medical Officer (MO) Work Level Standards

School of Pharmacy TEMPLE UNIVERSITY

Wales Patient Access Scheme: Process Guidance

SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS

Guide to Fees for Veterinary Products

Medical Device Regulatory Requirements for Taiwan

Marketing Authorisation Of A Product In Czech Republic

Authorisation and Restriction Newsletter

INFORMATION TECHNOLOGIES FOR PATIENT CARE MANAGEMENT

Masters Learning mode (Форма обучения)

College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board. Graadt van Roggenweg AH Utrecht The Netherlands

Unedited version adopted by the 45th WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organization 2010

RAPS ONLINE UNIVERSITY

Agreement. Double Degree Master s Program. International Relations. Between

REGULATORY OVERVIEW DISTRIBUTION OF PHARMACEUTICAL PRODUCTS

BUSINESS REGISTRATION HANDBOOK LIMITED LIABILITY WITH ONE MEMBERS

The 505(b)(2) Drug Development Pathway:

Kazan (Volga region) Federal University, Kazan, Russia Institute of Fundamental Medicine and Biology. Master s program.

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

NRA FUNCTION IN CONTROLLING VACCINES IN CLINICAL TRIAL AND MARKETING AUTHORIZATION INDONESIA 2013 DVI MEETING 9 11 APRIL

REGULATION (EEC) No 2309/93

Risk Management Plan (RMP) Guidance (Draft)

POST-MASTER S CERTIFICATES in ADVANCED QUALITY ASSURANCE or REGULATORY AFFAIRS

EUROPEAN INDUSTRIAL PHARMACISTS GROUP

EUROPASS DIPLOMA SUPPLEMENT

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Russia

Public Assessment Report. Scientific discussion. Calcium and Vitamine D3 Alpex 1000 mg/880 IE, effervescent granules

LAW ON MEDICINES. Article 1. Article 2. Article 3 Manufacturing and marketing of medical devices is the activity of public interest.

Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015

Drug Distribution Management Policy in Korea

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7

Hypromellose Eye Drops BP 0.3% w/v PL 23097/0006

Having regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;

External User Manual. Portal for Submission of Applications for the Update of the Manufacturing Flowchart as registered in INFARMED I.P.

GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.

EUROPASS DIPLOMA SUPPLEMENT

Draft guidance for registered pharmacies preparing unlicensed medicines

Zambia UK Health Workforce Alliance & Zambia Ministry of Health Conference

Med-Info Regular Information Bulletins for the Medical Device Industry

Volume 2B Notice to Applicants. Medicinal products for human use. Presentation and format of the dossier. Common Technical Document (CTD)

CTD Dossier Preparation. Sr.Manager-Regulatory Affairs

Guideline on good pharmacovigilance practices (GVP)

A clinical research organization

REACH-like regulations around the world. Dr. Adriana Jalba Manager, International Chemicals Management (ICM) Cefic

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE

The Clinical Trials Directive in the EU: Present and Future Elisabethann Wright, Partner Maurits Lugard, Partner. May 2010

THE BIOTECH & PHARMACEUTICAL INDUSTRY

Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan

CATEGORIES OF APPLICANTS AND DURATION OF SCHOLARSHIP

National Certificate in Pharmacy (Technician) (Level 5) with strands in Community, and Hospital Level 5

College ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg AH Utrecht The Netherlands

Information Letter. of Open Joint Stock Company RN Holding

Guideline on dossier requirements for Type IA and IB notifications

REGULATIONS FOR THE DEGREE OF BACHELOR OF PHARMACY IN CHINESE MEDICINE [PART-TIME] (BPharm[ChinMed])

TRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP

Cosmetic products in China

Agencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)

Ah-Reum Seo of Chemservice Asia introduces the forthcoming chemicals regulation for South Korea

MINISTER OF HEALTH. No: 4012/2003/QD BYT SOCIALIST REPUBLIC OF VIETNAM Independence Freedom Happiness Hanoi, 30 May DECISION

DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

The Medical Device Industry in Korea: Strategies for Market Entry

m 4 Biobank Alliance & m 4 Trial Service Center

QUALITY, SAFETY AND EFICACY ASSESSOR

What is a Lasting Power of Attorney?

Subject SA2 Life Insurance Specialist Applications Syllabus

ACADEMIC REGULATIONS FOR EHEA MASTER'S DEGREE COURSES AT THE UPC ACADEMIC YEAR

Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements

Нague Convention. on the Civil Aspects of International Child Abduction and its application in Russia. Every child has the right

ADMISSIONS. Qualification required

Annex 3 Procedure for prequalification of pharmaceutical products

The Postgraduate Course Toxicology Vienna

Somulose, 400 mg/25 mg/ml, Avlivningsvätska för djur Secobarbital Sodium. Applicant: Dechra Limited

Clinical Study Startup Timelines in Central and Eastern Europe

Subject SA2 Life Insurance Specialist Applications. Syllabus. for the 2013 Examinations. Institute and Faculty of Actuaries.

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON TABLET FRIABILITY GENERAL CHAPTER Q4B ANNEX 9(R1)

Overview. Health Science Authority. Implementation of ICH guideline in Singapore. Singapore s experience

EUROPASS DIPLOMA SUPPLEMENT

VOLUME 6A Procedures for marketing authorisation

CTC Technology Readiness Levels

Transcription:

PRESENTATION REGISTRATION OF PHARMACEUTICAL PRODUCTS IN RUSSIA Alyona Chorich, Regulatory Affairs Manager PharmaReg, Moscow 1. Registration in Russia conception. Pharmaceutical products / food supplements /cosmetics different registration ways. To enter into Russian market all pharmaceutical products must be registered. Registration is a procedure of expertise of the pharmaceutical product quality, efficacy and safety by State Regulatory Authority. After such expertise it is issued Registration Certificate and the product is introduced in the database of registered products in Russian Federation. From 2008 Registration Certificate is unlimited. But before this date Registration Certificates were issued only for 5 years. A big number of already registered products must pass re-registration. Registration Certificate is the same document as Marketing Authorization. In Russia there are 2 strictly divided categories: pharmaceutical products (one category) and food supplements and cosmetics (another category). The product must be associated with one from these categories. It is absent such category as curative cosmetics. The registration expertise of these 2 categories differs very much. Pharmaceutical products pass more detailed and strict examination; need more documentation and additional expertise. The most import legislative acts about registration of pharmaceutical products are: - Medicines Act 1998 - "Administrative Regulations of the Roszdravnadzor on execution of the state function of pharmaceutical products registration" approved by order of Ministry of Health and Social Development of Russian Federation No. 736 dated 30.10.2006. At the present moment it is under approval revised version of Medicines Act. 2. State Russian Regulatory Authorities (Roszdravnadzor, Rospotrebnadzor, National Center of Pharmaceutical Products Expertise (FGU), National Center of Nutrition) structure; interaction with applicants; differences in requirements for Russian and Foreigner Manufacturers. State Regulatory Authority is called Federal Service on Supervision in Sphere of Public Health Services and Social Development (Roszdravnadzor). Roszdravnadzor takes the decision to register the product and issues Registration Certificate. The expertise of all pharmaceutical products quality, efficacy and safety is done by National Center of Pharmaceutical Products Expertise (FGU). Only this National Center is authorized to execute independent expertise especially for Roszdravnadzor. According to new Medicines Act which is under approval additional Centers will be authorized to make registration expertise of pharmaceutical products. Structure of State Regulatory Authorities REGISTRATION CERTIFICATE ISSUING AUTHORITY ROSZDRAVNADZOR Department of pharmaceutical products registration

PHARMACEUTICAL PRODUCTS EFFICACY AND SAFETY EXPERTISE AUTHORITY National Center of Pharmaceutical Products Expertise (FGU) of Roszdravnadzor Section of coordination and data-base handling Institute of Products Quality Control Institute of Preclinical and Clinical Expertise Section of trade name expertise Quality Control Laboratory Specialized Commissions (bioequivalence, clinical, preclinical) National Center of Pharmaceutical Products Expertise consists from different Sections and Institutes. The biggest and the most important part of the registration procedure pass in the mentioned Center. Applicants for products registration submit registration documents directly to National Center. The registration procedure is organized in the way that regulatory affairs specials must communicate with experts every week. It is fixed the schedule of visiting days. Terms of registration depend a lot from the correctly organized work of the regulatory affairs specialist. The registration procedure is the same for Russian and Foreigner manufacturers. Differences appear in cost and documents. Also the important fact is that foreigner manufacturer must have GMP-certificate. The product is not necessary to be registered in the country of origin or another country. It is admitted to apply for registration products which will be authorized only in Russian Federation. State Regulatory Authorities are situated only in Moscow. There are absent divisions in other regions on Russian Federation. 3. Registration file list of documents, comparison of European and Russian registration files. Who can be the Applicant for registration, Marketing Authorization holder, Manufacturer? Official docs issued by Foreigner State Authorities legalization for Russia. Registration file (or dossier) represents the documents submitted to State Regulatory Authority for registration. Russian registration file consists from 6 parts: Administrative documents Description of pharmaceutical properties Data about manufacturing of pharmaceutical product Data about quality control of the finished pharmaceutical product Data about PRE-CLINICAL pharmacological and toxicological studies of pharmaceutical product Data about CLINICAL studies of pharmaceutical product European registration file consists from 5 modules. The structure of Russian and European registration files is very similar. If manufacturer has European registration file it is not necessary to prepare separated docs for Russia. All data required for Russian dossier are available in European file. Russian registration file must be presented to State Regulatory Authorities in Russian language.

In the Registration Certificate there are mentioned the following participants in Manufacturing process: Marketing Authorization Holder Manufacturer of the finished product Primary packaging Secondary packaging Batch release site On each of the above mentioned manufacturing stage can be indicated 2 companies. And also all of these stages can be represented by different companies. The important is to submit the contract agreement between all participants. The applicant for registration can be: Marketing Authorization Holder or its Representation in Russia Physical person Russian juridical company (third party) The rights to represent the interests of marketing Authorization Holder must confirmed by legalized Power of attorney. Thus it is not necessary to open Representation of the company in Russia especially to register pharmaceutical products. It is possible to register the products and after that to begin the business activity. Official documents such as Certificate of Pharmaceutical Product, GMP-certificate, Manufacturing License, Power of Attorney must be legalized. If the state of official documents issue is a State- Member of Hague Convention such documents must be apostilled. If not the documents must be legalized by Russian Embassy. 4. Registration of original and generic pharmaceutical products stages, terms and cost. Registration process conditionally can be divided into 3 basic stages Scheme of registration process Compiling of Registration dossier in Russian and its submission to the National Center of Pharmaceutical Products Expertise (FGU). I stage Expertise of the pharmaceutical product Quality, Efficacy and Safety in the National Center of Pharmaceutical Products Expertise (FGU). II stage Institute of Products Quality Control Quality Control Expertise Institute of Preclinical and Clinical Expertise Efficacy and Safety Expertise Finishing of the expertise and submission of the dossier to Roszdravnadzor for issuing of Registration Certificate. III stage At I stage of registration process it is necessary to collect all necessary documents, to translate them into Russian and to compile registration dossier.

The most difficult and longest is the II stage. Registration dossier after submission and payment of necessaries fees is directed to appointed experts from Institute of Products Quality Control and Institute of Preclinical and Clinical Expertise. In the Institute of Products Quality Control it is done the verification of Finished Product Specification called in Russian Normative Document and also is performed the laboratory control. In the Institute of Preclinical and Clinical Expertise it is checked the Instruction for administration. In case if necessity of preclinical or clinical tests the product is directed to specialized Research Institute. Original and generic products pass the same stages of registration. Original products must pass through all registration procedures while the generic products are exempted from some of them. For example for original product must conducted clinical trials in Russia. For generic products can be conducted only bioequivalence studies and not only in Russia. Preclinical and clinical studies performed in foreigner countries are accepted. Terms of registration process: I stage + II stage + III stage 2 months 12 months 4 months = TOTAL 18 months The time of registration can be increased in the following cases: The necessity to carry out of additional preclinical and clinical trials The necessity to carry out of repeated laboratory quality control. Delay of granting of additional required data by State Regulatory Authority more than 30 days. COST OF REGISTRATION The cost of registration of one pharmaceutical product consists from 2 parts: Official payments to State Authorities + payment of regulatory affairs specialist or company services = approx.36000 $ + 13000 $ = approx. 49000 $ approx.29000 + approx.10000 $ = approx. 39000 $ OFFICIAL PAYMENTS paid to State Authority (National Center of Pharmaceutical Products Expertise (FGU)) for one pharmaceutical product registration for foreigner manufacturers are the following: Name of procedure Cost, $ Cost, Note Examination of documents (one registration dossier) 22000-30000 $ 16000 25000 The whole sum must be paid at the beginning of the registration process. The registration expertise will not begin until the customer will not pay the invoice.

Laboratory quality expertise 2 000-6 000 $ TOTAL 24 000-36000 $ 1.400 4000 17400 29000 The cost of Laboratory quality expertise depends on the number of dosages and the analytical methods used. 5. Laboratory Control of pharmaceutical products during registration and post-registration Control at the stage of import for selling (essential moments, possible difficulties). During registration process all products must pass laboratory control according to approved Normative Document. Possible difficulties are: necessary of introduction in finished product specification of additional tests, importing of standards and samples. Normative Document in Russia is compiled according to manufacturer s finished product specification, European/British Pharmacopoeia, United States Pharmacopoeia and Russian Pharmacopoeia. To import the samples and standards for laboratory control it is necessary to receive special Import permission from Roszdravnadzor. It takes 1-2 months and prolonged the time of registration. The full analysis of the pharmaceutical product is done on the stage of registration and on the first 3 batched imported into Russian market for selling. The time of laboratory control is 4 months, plus 2 months to import necessary standards. It is necessary to take in consideration that within this time (6 months) the product will be holed at the custom. 6. Post-Registration Variations types, documents, terms. The result of registration process is obtaining of Registration Certificate. Along with it are given Normative Document, Instruction for administration and Colored design of packaging. All these documents are signed by representative of the License Authorization (Registration Certificate) Holder and approved by Roszdravnadzor. Any changes introduced in these documents must be approved by State Regulatory Authority as Variation. There are 2 types of Variations: Type Classification Examples Variation type I Don t need Quality, Efficacy or Safety expertise Variation type II Need Quality, Efficacy or Safety expertise Change of the Manufacturer s name; Change of Marketing Authorization holder; Change of package design Change of manufacturing site; change of quality or quantity composition; change of instruction for administration Terms of variation approval: Type Variation type I Variation type II Terms 2-3 months 6-12 months